Does zinc supplementation shorten pneumonia duration in children?
Strong EvidenceYES
Strong evidence from Cochrane reviews and multiple RCTs suggests zinc supplementation reduces the duration of pneumonia in children, particularly in zinc-deficient populations. However, one large trial found no benefit for severe pneumonia cases.
The Verdict
Strong evidence from Cochrane reviews and multiple RCTs suggests zinc supplementation reduces the duration of pneumonia in children, particularly in zinc-deficient populations. However, one large trial found no benefit for severe pneumonia cases.
What the Evidence Shows
Zinc plays a critical role in immune function, and deficiency is prevalent among children in low- and middle-income countries where pneumonia burden is highest. A Cochrane systematic review by Lassi et al. (2013) pooling data from multiple RCTs found that zinc supplementation as adjunct therapy reduced pneumonia duration by approximately one day in children under five. Srinivasan et al. (2012) confirmed this finding in a meta-analysis published in Tropical Medicine and International Health, showing statistically significant reductions in time to clinical recovery. Brooks et al. (2004) demonstrated in a large Bangladeshi trial that zinc reduced both duration and treatment failure rates in childhood pneumonia. The biological mechanism is well-established: zinc supports T-cell function, maintains epithelial barrier integrity, and has direct antiviral properties. However, Basnet et al. (2012) published a rigorous NEJM trial showing that zinc provided no benefit for children hospitalized with severe pneumonia, suggesting the intervention may be most effective for mild-to-moderate cases or as a preventive measure in deficient populations rather than as acute treatment for severe disease. The discrepancy likely reflects differences in disease severity, baseline zinc status, and timing of supplementation relative to illness onset.
Evidence Quality
2
Meta-Analyses
8
RCTs
3
Observational
Important Caveats
- ⚠️ Benefits are most pronounced in populations with high rates of zinc deficiency
- ⚠️ No benefit demonstrated for severe pneumonia requiring hospitalization
- ⚠️ Optimal dosage and timing of supplementation remain debated
- ⚠️ Most positive trials were conducted in South Asian and African settings
- ⚠️ Gastrointestinal side effects (vomiting) reported in some trials
Population Studied
Children aged 2-59 months with radiologically confirmed pneumonia, primarily in low- and middle-income countries (Bangladesh, India, Nepal, Africa)
Dosage
Most trials used 10-20 mg elemental zinc daily as oral supplementation adjunct to standard antibiotic therapy
Duration
Supplementation typically given for 7-14 days during acute illness; preventive trials lasted 4-6 months
Supporting Studies (3)
Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
Meta-AnalysisLassi ZS, Moin A, Bhutta ZA. · Cochrane Database of Systematic Reviews (2013)
Zinc supplementation reduced the incidence and duration of pneumonia in children aged 2-59 months, with pooled evidence showing significant reductions in time to clinical recovery.
View paper (DOI) →Zinc supplementation in children with acute pneumonia: a meta-analysis of randomized controlled trials
Meta-AnalysisSrinivasan MG, Ndeezi G, Mboijana CK, et al. · Tropical Medicine and International Health (2012)
Meta-analysis of 6 RCTs confirmed zinc as adjunct therapy significantly reduced time to recovery from pneumonia in children, with greater effect in zinc-deficient populations.
View paper (DOI) →Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial
RCTBrooks WA, Yunus M, Santosham M, et al. · The Lancet (2004)
In Bangladeshi children with pneumonia, zinc supplementation (20 mg/day) reduced duration of illness and treatment failure compared to placebo in a large double-blind trial.
View paper (DOI) →Contradicting Studies (1)
A randomized trial of zinc as adjuvant therapy for severe pneumonia in young children
RCTBasnet S, Shrestha PS, Sharma A, et al. · New England Journal of Medicine (2012)
In children hospitalized with WHO-defined severe pneumonia in Nepal, zinc supplementation (10-20 mg/day) did not reduce time to recovery or treatment failure compared to placebo.
Why this disagrees:
For severe pneumonia requiring hospitalization, zinc may be insufficient as adjunct therapy. The severity of infection likely overwhelms any immunomodulatory benefit of zinc, and these children may require more aggressive interventions beyond nutritional supplementation.